Evidence map›Paper›PMID 39000249›Full record

ReviewInternational journal of molecular sciences2024

Role of Kynurenine and Its Derivatives in the Neuroimmune System.

Makoto Fujikawa, Masashi Ueda, Kenta Maruyama

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Metabolic Brain Disorders: Prodromes, Symptoms, and Syndromes.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Review
  6. Degradation of the Molecular Basis of Life During the Aging Process.International journal of molecular sciences · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Makoto FujikawaDepartment of Pharmacology, School of Medicine, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.ORCID 0000-0002-8100-3718
Masashi UedaDepartment of Pharmacology, School of Medicine, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.
Kenta MaruyamaDepartment of Pharmacology, School of Medicine, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, there has been a growing realization of intricate interactions between the nervous and immune systems, characterized by shared humoral factors and receptors. This interplay forms the basis of the neuroimmune system, the understanding of which will provide insights into the pathogenesis of neurological diseases, in which the involvement of the immune system has been overlooked. Kynurenine and its derivatives derived from tryptophan have long been implicated in the pathogenesis of various neurological diseases. Recent studies have revealed their close association not only with neurological disorders but also with sepsis-related deaths. This review provides an overview of the biochemistry of kynurenine and its derivatives, followed by a discussion of their role via the modulation of the neuroimmune system in various diseases.

Indexed as

KynurenineNeuroimmunomodulationAnimalsHumansImmune SystemNervous System DiseasesSepsisTryptophanKynurenineTryptophanbrainkynurenine pathwayneuroimmunologysepsistryptophan

Identifiers

PMID39000249
PMCPMC11241229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.